GPP
DRNA

Great Point Partners’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Great Point Partners’s Portfolio DRNA Stock Details DRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-799,999
Closed -$16.1M – 49
2021
Q3 		$16.1M Buy
+799,999
New +$16.1M 3.76% 7